Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Rapid and Sustained Eyelid Elevation in Acquired Blepharoptosis with Oxymetazoline 0.1%: Randomized Phase 3 Trial Results

Jason Bacharach,1 David L Wirta,2 Robert Smyth-Medina,3 Michael S Korenfeld,4 Shane R Kannarr,5 Shane Foster,6 Mark J Jaros,7 Charles B Slonim8 1North Bay Eye Associates, Petaluma, CA, USA; 2Aesthetic Eye Care Institute & Eye Research Foundation, Newport Beach, CA, USA; 3North Valley Eye Medical...

Full description

Bibliographic Details
Main Authors: Bacharach J, Wirta DL, Smyth-Medina R, Korenfeld MS, Kannarr SR, Foster S, Jaros MJ, Slonim CB
Format: Article
Language:English
Published: Dove Medical Press 2021-06-01
Series:Clinical Ophthalmology
Subjects:
alpha adrenergic agonist
eye drop
müller's muscle
non-surgical
topical
pharmacologic
Online Access:https://www.dovepress.com/rapid-and-sustained-eyelid-elevation-in-acquired-blepharoptosis-with-o-peer-reviewed-fulltext-article-OPTH

Internet

https://www.dovepress.com/rapid-and-sustained-eyelid-elevation-in-acquired-blepharoptosis-with-o-peer-reviewed-fulltext-article-OPTH

Similar Items